Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

512px-ursula_von_der_leyen

European Commission offers €80m to CureVac to develop coronavirus vaccine

March 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus

Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …
News
novo_nordisk_flag

Novo Nordisk halts three haemophilia studies after participants suffer thrombotic events

March 17, 2020 Manufacturing and Production, Research and Development Novo Nordisk, haemophilia, pharma

Novo Nordisk has moved to temporarily shut down two of its Phase 3 and one of its Phase 2 clinical …
News
astrazeneca_building_white

Success and failure at Phase 3 for AstraZeneca’s Imfinzi combos in first-line small cell lung cancer

March 17, 2020 Manufacturing and Production, Research and Development AstraZeneca, Cancer, Imfinzi, pharma

AstraZeneca has pulled back the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage …
News
moderna_norwood_plant

Human dosing begins for first US coronavirus vaccine

March 17, 2020 Manufacturing and Production, Research and Development Moderna, Vaccine, coronavirus, pharma

The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …
News
anthony_mancini

Genmab announces newly-created Chief Financial Officer appointment

March 16, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …
Appointment
shutterstock_159488225

Bavencio Phase 3 head and neck cancer trial terminated

March 16, 2020 Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure

Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …
News
shutterstock

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020 Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …
News
shutterstock_38078521

AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer

March 13, 2020 Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus

HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …
News
fda2outsideweb

FDA halts overseas inspections over coronavirus concerns

March 11, 2020 Research and Development, Sales and Marketing FDA, US, approvals, pharma

The FDA has responded to the ongoing COVID-19 coronavirus outbreak by announcing that it will halt all inspections of overseas …
News

Ameluz approved by European Commission for treatment for actinic keratosis

March 11, 2020 Research and Development EC, EMA, Europe, Lesions

Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …
News
takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro combo fails to hit main goal in newly diagnosed, transplant ineligible multiple myeloma

March 11, 2020 Research and Development, Sales and Marketing Ninlaro, Takeda, multiple myeloma, pharma

Takeda has unveiled new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib) in the treatment of newly diagnosed …
News

A man from London becomes second person to be cured of HIV

March 11, 2020 Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV

Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …
News
mitchell_web

Data science firm Genomics Plc names new Chief Strategy Officer

March 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genomics, pharma

Data science firm Genomics Plc, which lays claim to “the world’s largest genomic database”, has welcomed Mitchell Harris to the …
Appointment
conference_peach

The American Academy of Allergy, Asthma and Immunology calls off its 2020 Annual Meeting due to coronavirus concerns

March 10, 2020 Medical Communications, Research and Development Big Pharma, allergy, america, asthma, immunology

The American Academy of Allergy, Asthma and Immunology (AAAAI) has called off its 2020 Annual Meeting that was schedule to …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026